Sienna M Durbin1, Debra Lundquist2, Andrea Pelletier3

  • 1Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts, USA.

Cancer
|October 10, 2024
PubMed
概括

在早期临床试验 (EP-CT) 中,超过三分之一的患者经历了财务毒性. 这种财务负担与生活质量下降以及对资源的担忧增加有关,这凸显了对支持的需求.